Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

EPIQ 7 Ultrasound System Recalled by Philips Ultrasound, Inc. Due to When using the QLAB Auto 2D Quantification (a2DQ)...

Date: November 5, 2014
Company: Philips Ultrasound, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Philips Ultrasound, Inc. directly.

Affected Products

EPIQ 7 Ultrasound System, EPIQ 7 systems with software versions 1.0.x or 1.1.x with QLAB a2DQ and/or aCMQ plug-ins are affected. Model: EPIQ 7G, EPIC 7C, EPIQ 7W; Catalog Number: 795200 / 795201 and Part Number: 989605386721. Diagnostic Ultrasound Imaging.

Quantity: 701 units (237 in the US and 464 outside US)

Why Was This Recalled?

When using the QLAB Auto 2D Quantification (a2DQ) and Auto Cardiac Motion Quantification (aCMQ) applications, the reported End-Systolic Volume (ESV) may be smaller, and the Left Ventricular Ejection Fraction (EF) may be higher, than the ESV and EF calculated by manual tracing without the use of QLAB. An incorrect EF calculation could lead to misdiagnosis and/or delayed or incorrect therapy.

Where Was This Sold?

This product was distributed to 32 states: AK, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, ME, MD, MA, MI, MN, MO, NJ, NY, NC, OH, OR, PA, SC, SD, TN, TX, VA, WA, WI, DC

Affected (32 states)Not affected

About Philips Ultrasound, Inc.

Philips Ultrasound, Inc. has 17 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report